Science Daily

AI model can reveal the structures of crystalline materials

Then, they began testing the model on diffraction patterns that hadn't been solved before. This data came from the Powder Diffraction File, which contains diffraction data for more than 400,000 solved ...
Rutland Herald

Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Meclizine (Generic Dramamine(R))

New delivery system targets rapid-onset relief for motion sickness and vertigo, modernizing the $450M global market for the active ingredient in Dramamine®. Meclizine was the top-prescribed antiemetic ...
Journal Star

Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Ondansetron (Generic Zofran(R))

Near-Instant Absorption: Bypasses the gastrointestinal tract and first-pass metabolism, potentially reducing onset of action from 30 minutes to just minutes. Clinical Comparability: Designed to mirror ...
The Independent

Epstein file redactions reveal victims as young as nine and implicate a high-level government official, lawmakers say

The remaining Department of Justice files on Jeffrey Epstein include the revelation that one of the pedophile’s victims was just nine years old and that a senior official in a foreign government was ...
Yahoo Finance

Aspire files patent application for clopidogrel sublingual powder formulation

Aspire Biopharma (ASBP) announced the filing of a new provisional patent application with the United States Patent and Trademark Office. The application, titled “A Sublingual Powder Formulation of ...
Yahoo Finance

Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Powder Formulation of Clopidogrel (Generic Plavix(R)) to Address Gastric Bleeding Risks

New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel. Clopidogrel, currently sold under the brand name Plavix&reg ...
Investing

Aspire Biopharma files patent for first sublingual alprazolam powder

ESTERO, FLORIDA - Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) announced Tuesday it has filed a provisional patent application with the U.S. Patent and Trademark Office for a sublingual powder ...